Fung Capital is a Shenzhen-based venture capital firm founded in 2007 that invests in healthcare and life sciences companies, including biotechnology, pharmaceuticals, medical devices and HealthTech. It backs companies in China and the United States, with later-stage venture exposure, and has led investments in healthcare portfolio companies including Chipscreen Biosciences, Ascentage Pharma, Frontier Biotech, Insight Lifetech and Harbour BioMed. The firm is most relevant to founders building life sciences, biopharmaceutical or medical device companies seeking a China-connected healthcare investor.